Streamline Health Solns Q4 Sales $6.00M Beat $5.16M Estimate
Streamline Health Solns (NASDAQ:STRM) reported quarterly sales of $6.00 million which beat the analyst consensus estimate of $5.16 million by 16.28 percent. This is a 101.75 percent increase over sales of $2.97 million